×
About 796 results

ALLMedicine™ Pericarditis Center

Research & Reviews  377 results

Coronavirus disease 2019 (COVID-19)-associated constrictive pericarditis.
https://doi.org/10.1136/bcr-2021-242018
BMJ Case Reports; Beckerman JK, Alarfaj M et. al.

May 12th, 2021 - This report documents a rare case of COVID-19-associated constrictive pericarditis (CP) in the setting of a recent COVID-19 infection. A 55-year-old man with a history of hypertension and gout presented with acute hypoxic respiratory failure and w...

Role of Immunosuppressive Therapy in the Management Refractory Post-Procedural Pericard...
https://doi.org/10.1111/jce.15069
Journal of Cardiovascular Electrophysiology; Narasimhan B, Turagam MK et. al.

May 4th, 2021 - A significant rise in epicardial based interventions over the past two decades has been associated with a proportionate rise in complications - most notably, pericarditis. Post procedural pericarditis is often particularly refractory to convention...

Multimodality imaging of constrictive pericarditis in H syndrome.
https://doi.org/10.1111/echo.15027
Echocardiography (Mount Kisco, N.Y.); Malakan Rad E, Yaghmaei B et. al.

Apr 26th, 2021 - This is the first report of constrictive pericarditis (CP) in a 16-year-old boy with H syndrome with pericardial involvement predominantly over the right ventricle with favorable response to anti-inflammatory treatment. H syndrome, first reported ...

Health-related quality of life in patients with recurrent pericarditis: results from a ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061027
BMC Cardiovascular Disorders; Lin D, Klein A et. al.

Apr 22nd, 2021 - Impact of recurrent pericarditis (RP) on patient health-related quality of life (HRQoL) was evaluated through qualitative patient interviews and as an exploratory endpoint in a Phase 2 trial evaluating the efficacy and safety of rilonacept (IL-1α/...

Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic rev...
https://doi.org/10.1136/heartjnl-2020-318869
Heart (British Cardiac Society); Imazio M, Andreis A et. al.

Mar 19th, 2021 - Corticosteroid-dependent and colchicine-resistant recurrent pericarditis (RP) is a challenging management problem, in which conventional anti-inflammatory therapy (nonsteroidal anti-inflammatory drugs, colchicine, corticosteroids) is unable to con...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  401 results

Coronavirus disease 2019 (COVID-19)-associated constrictive pericarditis.
https://doi.org/10.1136/bcr-2021-242018
BMJ Case Reports; Beckerman JK, Alarfaj M et. al.

May 12th, 2021 - This report documents a rare case of COVID-19-associated constrictive pericarditis (CP) in the setting of a recent COVID-19 infection. A 55-year-old man with a history of hypertension and gout presented with acute hypoxic respiratory failure and w...

Role of Immunosuppressive Therapy in the Management Refractory Post-Procedural Pericard...
https://doi.org/10.1111/jce.15069
Journal of Cardiovascular Electrophysiology; Narasimhan B, Turagam MK et. al.

May 4th, 2021 - A significant rise in epicardial based interventions over the past two decades has been associated with a proportionate rise in complications - most notably, pericarditis. Post procedural pericarditis is often particularly refractory to convention...

Multimodality imaging of constrictive pericarditis in H syndrome.
https://doi.org/10.1111/echo.15027
Echocardiography (Mount Kisco, N.Y.); Malakan Rad E, Yaghmaei B et. al.

Apr 26th, 2021 - This is the first report of constrictive pericarditis (CP) in a 16-year-old boy with H syndrome with pericardial involvement predominantly over the right ventricle with favorable response to anti-inflammatory treatment. H syndrome, first reported ...

Health-related quality of life in patients with recurrent pericarditis: results from a ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061027
BMC Cardiovascular Disorders; Lin D, Klein A et. al.

Apr 22nd, 2021 - Impact of recurrent pericarditis (RP) on patient health-related quality of life (HRQoL) was evaluated through qualitative patient interviews and as an exploratory endpoint in a Phase 2 trial evaluating the efficacy and safety of rilonacept (IL-1α/...

Arcalyst - rilonacept injection, powder, lyophilized, for solution-Kiniksa Pharmaceuticals (UK), Ltd.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad965f38-dd22-4607-a673-2fb92f3b527a

Mar 30th, 2021 - ARCALYST (rilonacept) is an interleukin-1 blocker indicated for: Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS), and Muckle-Wells Syndrome (MWS) in adults and children 12 year...

see more →

News  4 results

Adjuvant Colchicine Halves Rate of Subsequent Pericarditis Recurrences
https://www.mdedge.com/internalmedicine/article/37334/cardiology/adjuvant-colchicine-halves-rate-subsequent-pericarditis
Patrice Wendling

Sep 8th, 2011 - PARIS – In patients with a first recurrence of pericarditis, adding low-dose colchicine to standard therapy halved the risk of subsequent episodes of pericarditis. Among 120 patients with a first recurrence of pericarditis in the Study of Colchici.

CORP: Colchicine Prevents Recurrent Pericarditis
https://www.medscape.com/viewarticle/748686

Aug 27th, 2011 - August 28, 2011 (Paris, France) — Italian researchers have shown that colchicine, when given in addition to conventional therapy, prevents recurrent episodes of pericarditis [1]. Specifically, the study, Colchicine for Recurrent Pericarditis (CORP...

CORP: Colchicine Prevents Recurrent Pericarditis
https://www.staging.medscape.com/viewarticle/748686

Aug 27th, 2011 - August 28, 2011 (Paris, France) — Italian researchers have shown that colchicine, when given in addition to conventional therapy, prevents recurrent episodes of pericarditis [1]. Specifically, the study, Colchicine for Recurrent Pericarditis (CORP...

Rare Disease Offers Pediatric Rheumatology Insights : Report details genetic mutation in the joint condition camptodactyly-arthropathy-coxa vara-pericarditis.
https://www.mdedge.com/rheumatology/article/43045/rheumatoid-arthritis/rare-disease-offers-pediatric-rheumatology-insights
Diana Mahoney

The recent identification of novel gene mutations in seven Saudi Arabian children with camptodactyly-arthropathy-coxa vara-pericarditis syndrome has implications beyond the rare autosomal recessive joint condition, as it provides researchers with.

see more →

Patient Education  13 results see all →